<DOC>
	<DOCNO>NCT00354419</DOCNO>
	<brief_summary>RATIONALE : Giving chemotherapy total-body irradiation donor umbilical cord blood stem cell transplant help stop growth abnormal cell . It also help stop patient 's immune system reject donor 's stem cell . When healthy stem cell donor infused patient may help patient 's bone marrow make stem cell , red blood cell , white blood cell , platelet . Sometimes transplanted cell donor make immune response body 's normal cell . Giving cyclosporine mycophenolate mofetil transplant may stop happen . PURPOSE : This phase I trial study side effect best dose total-body irradiation give together cyclophosphamide antithymocyte globulin treat patient severe aplastic anemia undergo umbilical cord blood transplant .</brief_summary>
	<brief_title>Cyclophosphamide , Antithymocyte Globulin , Total-Body Irradiation Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant</brief_title>
	<detailed_description>OBJECTIVES : I . The objective study determine low dose total body irradiation combine cyclophosphamide antithymocyte globulin achieve sustain engraftment patient severe aplastic anemia transplant unrelated umbilical cord blood . OUTLINE : This dose-escalation study total-body irradiation ( TBI ) . MYELOABLATIVE CONDITIONING REGIMEN : Patients receive cyclophosphamide IV day -7 -4 , -6 -3 , -5 -2 antithymocyte globulin IV day -6 -4 , -5 -3 , -4 -2 . TBI : Patients undergo TBI twice daily day -3 , -2 , and/or -1 . UMBILICAL CORD BLOOD TRANSPLANTATION ( UCBT ) : Patients undergo UCBT day 0 . Patients receive filgrastim ( G-CSF ) IV subcutaneously begin day 1 continue blood count recover . GRAFT-VS-HOST DISEASE ( GVHD ) PROPHYLAXIS : Patients receive cyclosporine IV orally ( twice daily patient &gt; = 6 year age 3 time daily patient &lt; 6 year age ) day -1 +180 mycophenolate mofetil IV orally ( twice daily patient &gt; = 50 kg 3 time daily patient &lt; 50 kg ) begin 4 hour UCBT continue approximately day +0 . After completion study therapy , patient follow periodically .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Lifethreatening marrow failure nonmalignant etiology meeting two three follow criterion : granulocyte &lt; 500/mm^3 ; correct reticulocyte count &lt; 1 % ; platelet count &lt; 20,000/mm^3 Failure respond best available immunosuppressive treatment protocol 75 day initiation therapy Lack HLAidentical family member closely match ( 9 10 10 HLAlocus match ) unrelated marrow donor DONOR : Unrelated UCB unit match least 4 6 loci DONOR : Related UCB unit match least 3 6 lock Selection UCB unit ( ) base upon match mismatch HLAA , B antigen level DRB1 allele level typing ; HLAC antigen/allele HLADQB1 antigen/allele level type consider matching criterion , available may use optimize unit selection Multiple UCB unit allow provide sufficient cell dose ; multiple unit select , follow rule apply : ) UCB unit least HLA disparity select first ( i.e. , selection priority 6/6 match &gt; 5/6 match &gt; 4/6 match ) , additional UCB unit may select increase cell dose ; b ) UCB unit must match least 4 6 locus ; c ) unit must contain least 1.5 x 10^7 Total Nucleated Cells per kg recipient weight ; ) total cell dose combine unit must least 3.0 x 10^7 Total Nucleated Cells per kg recipient weight Severe disease aplastic anemia would severely limit probability survival graft procedure ; patient present active fungal infection must treat resolve problem begin condition regimen HIV seropositive patient Patients develop clonal cytogenetic abnormality myelodysplastic syndrome ( patient consider separate protocol myelodysplastic syndrome , etc . ) Patients paroxysmal nocturnal hemoglobinuria Fanconi anemia Patients &gt; 40 year age Related unrelated cord blood unit &lt; 1.5 x 10^7 Total Nucleated Cells per kg recipient weight Related unrelated cord blood unit without full test negative result hepatitis A , B , C , HIV , HTLV1 , CMV virus</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>